Orchid BioSciences, Inc. (ORCH) To Present At The UBS Global Healthcare Services Conference 
10/19/2005 5:12:44 PM

PRINCETON, N.J., Feb. 15 /PRNewswire-FirstCall/ -- Orchid BioSciences, Inc. , a leading provider of identity DNA testing services, today announced that Paul J. Kelly, M.D., chief executive officer of Orchid, is scheduled to present at the UBS Global Healthcare Services Conference in New York City on Wednesday, February 16, 2005 at 1:00 p.m. ET.

Dr. Kelly will provide a brief corporate overview and discuss the company's recent progress. A live webcast of Dr. Kelly's presentation can be accessed at, by clicking on the Conferences box in the middle of the page and then selecting the webcast link for the Global Healthcare Services Conference. Alternatively, the webcast will be available via the Investor Relations section of Orchid's website at The archived webcast will be available starting approximately three hours after the presentation and will be archived through March 16, 2005.

About Orchid BioSciences

Orchid BioSciences is a leading provider of identity genetics services for the forensic and paternity DNA testing markets and for public health DNA testing for food safety. Orchid's strong market positions in these segments leverage the company's accredited laboratories in the U.S. and U.K., its innovative genetic analysis technologies and expertise, and the world-renowned Cellmark and GeneScreen brands that have been associated with exceptional quality, reliability, innovation and customer service for nearly two decades. More information on Orchid can be found at

Orchid BioSciences, Inc.

CONTACT: Tracy J. Henrikson, Executive Director, CorporateCommunications, Orchid BioSciences, Inc., +1-609-750-2221